Coherus Biosciences reported $-32787000 in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -15301000 28.41M
Aerie Pharmaceuticals AERI:US $ -32374000 873K
Akebia Therapeutics AKBA:US $ -54886000 24.46M
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
ALKERMES ALKS:US -19659000 24.08M
Alnylam Pharmaceuticals ALNY:US $ -181677000 35.52M
Amarin AMRN:US 1.04M 7.73M
Amgen AMGN:US $ 2378M 45M
Baxter International BAX:US $ 616M 140M
Biogen BIIB:US $ 858.6M 171.5M
Biomarin Pharmaceutical BMRN:US $ -35997000 47.67M
Bluebird Bio BLUE:US $ -196779000 44.06M
Bristol Myers Squibb BMY:US $ 2985M 18M
Coherus Biosciences CHRS:US $ -32787000 8.62M
Eli Lilly And LLY:US $ 2055.2M 626.8M
Endo International Ordinary Shares ENDP:US $ 207.28M 11.74M
Fujifilm 4901:JP 51.54B 4.77B
Gilead Sciences GILD:US $ 3883M 1637M
Horizon Pharma HZNP:US 345.45M 131.68M
Ironwood Pharmaceuticals IRWD:US $ 65.1M 282K
JAZZ PHA JAZZ:US 28.37M 97.96M
Merk MRK:US $ 5352M 3083M
Myriad Genetics MYGN:US $ -79900000 60.9M
Pacira Pharmaceuticals PCRX:US $ 30.72M 4.27M
Perrigo Ordinary Shares PRGO:US $ 454.4M 410.3M
Pfizer PFE:US $ 9254M 2592M
Ptc Therapeutics PTCT:US $ -93076000 5.42M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Sarepta Therapeutics SRPT:US $ -34458000 133.12M
Teva Pharmaceutical TEVA:IT 806M 23M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M
Xencor XNCR:US $ -41300000 50.39M
Zoetis ZTS:US $ 735M 9M